+41.1%
GSK vs SPXS
-77.8%
+118.9%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SPXS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | +10.7% | -10.9% | +1.0% |
| 7D | -5.3% | +29.1% | -34.5% | -2.6% |
| 30D | -3.7% | +37.6% | -41.3% | -0.1% |
| 3M | -7.3% | +33.3% | -40.5% | -4.1% |
| 6M | -4.2% | +22.7% | -26.9% | -1.7% |
| YTD | +0.9% | -4.2% | +5.0% | +1.2% |
| 1Y | +7.3% | -15.9% | +23.1% | +6.2% |
| 3Y | +52.7% | -71.9% | +124.6% | +36.5% |
| All | +41.1% | -77.8% | +118.9% | +26.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXS.
Daily Out/Under-Performance
Portfolio return minus SPXS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SPXS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling